Pediatr Allergy Immunol. 2019;00:1–10. wileyonlinelibrary.com/journal/pai | 1 © 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. 1 | INTRODUCTION The European Academy of Allergy and Clinical Immunology (EAACI) journals have reported on the prediction and primary and secondary preventions of allergic diseases and asthma. Besides, food allergy (FA) and rhinitis and asthma were main topics in 2017. 1,2 FA can result in considerable morbidity, impairment of quality of life, and increased healthcare expenditure. As an important contribution to the area, EAACI developed a guideline on FA immunotherapy with the work of the Task Force on Allergen Immunotherapy (AIT) for IgE‐ mediated FA. The Task Force provides evidence‐based recommen‐ dations for active treatment of IgE‐mediated FA with FA‐AIT. 3 This paper summarizes the achievements published in 2018 for anaphy‐ laxis, and food and drug allergy. Received: 11 September 2019 | Accepted: 17 September 2019 DOI: 10.1111/pai.13125 REVIEW ARTICLE Food and drug allergy, and anaphylaxis in EAACI journals (2018) Philippe A. Eigenmann 1 | Cezmi Akdis 2 | Jean Bousquet 3,4,5,6 | Clive E. Grattan 7 | Karin Hoffmann‐Sommergruber 8 | Marek Jutel 9,10 Abbreviations: DBPCFC, double‐blind, placebo‐controlled food challenge; DHRs, drug hypersensitivity reactions; OFC, oral food challenge; OIT, oral immunotherapy. 1 Pediatric Allergy Unit, University Hospitals of Geneva, Geneva, Switzerland 2 Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland 3 MACVIA‐France, Fondation partenariale FMC VIA‐LR, Montpellier, France 4 INSERM U 1168, VIMA: Ageing and Chronic Diseases ‐ Epidemiological and Public Health Approaches, Villejuif, France 5 UMR‐S 1168, Université Versailles St‐Quentin‐en‐Yvelines, Montigny le Bretonneux, France 6 Euforea, Brussels, Belgium 7 St John’s Institute of Dermatology, Guy’s Hospital, London 8 Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria 9 Department of Clinical Immunology, Wroclaw Medical University, Wrocław, Poland 10 ALL‐MED Medical Research Institute, Wrocław, Poland Correspondence Philippe Eigenmann, Pediatric Allergy Unit, University Hospitals of Geneva, Geneva, Switzerland. Email: philippe.eigenmann@hcuge.ch Editor: Alexandra Santos Abstract The European Academy of Allergy and Clinical Immunology (EAACI) supports three journals: “Allergy,” “Pediatric Allergy and Immunology (PAI),” and “Clinical and Translational Allergy (CTA).” One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to dis‐ seminate the knowledge of allergy to all stakeholders including the EAACI junior members. This paper summarizes the achievements of 2018 in anaphylaxis, and food and drug allergy. Main topics that have been focused are anaphylaxis, mechanisms of food allergy (FA), epidemiology of FA, food allergens, diagnosis of FA, prevention and control of FA, FA immunotherapy, drug allergy, and political agenda. KEYWORDS allergy, anaphylaxis, Clinical and Translational Allergy, drug allergy, European Academy of Allergy and Clinical Immunology, food allergy, hypersensitivity, Pediatric Allergy and Immunology